This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wüst, J.
Right arrow Articles by Wilkins, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wüst, J.
Right arrow Articles by Wilkins, T. D.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1978 September; 14(3): 384-390
Copyright © 1978 American Society for Microbiology. All Rights Reserved.

Susceptibility of Anaerobic Bacteria to Sulfamethoxazole/Trimethoprim and Routine Susceptibility Testing

Jürg Wüst1 and Tracy D. Wilkins2

1 Institute for Medical Microbiology, University of Zurich, CH-8028 Zurich, Switzerland
2 Anaerobe Laboratory, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24060

ABSTRACT

The minimal inhibitory concentrations (MICs) of sulfamethoxazole and trimethoprim against 144 strains of obligately anaerobic bacteria were determined on Diagnostic Sensitivity Test agar (Oxoid) or in prereduced Diagnostic Sensitivity Test broth, both supplemented with sodium pyruvate (1 mg/ml), hemin (5 µg/ml), and vitamin K1 (1 µg/ml). Fifty-eight percent of the strains were susceptible to sulfamethoxazole alone (MIC ≤ 16 µg/ml), only 12% were susceptible to trimethoprim alone (MIC ≤ 1 µg/ml), and 85% were susceptible to the combination of sulfamethoxazole plus trimethoprim (MIC ≤ 16 µg/ml) at a ratio of 19:1. All 45 strains of the Bacteroides fragilis group were susceptible to the combination. Synergy of the combination was often observed by a checkerboard MIC determination of 123 strains, usually most markedly when the ratio of the two components was near 1:1. However, there was also synergism at the ratio of sulfamethoxazole to trimethoprim of 16:1 in 61 (53.5%) of the 114 strains that could be evaluated for synergistic activity. When the strains were tested by the broth-disk test proposed by Wilkins and Thiel, modified by using prereduced Diagnostic Sensitivity Test broth instead of brain heart infusion broth and by using a smaller inoculum, there was over 90% correlation with the MICs. Poor results were found when the broth-disk tests were performed in brain heart infusion broth. There was very poor correlation between inhibition zone diameters by an agar diffusion method and MICs.


Antimicrob Agents Chemother. 1978 September; 14(3): 384-390
Copyright © 1978 American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Paker, G. E., Graham, J. A., Rauch, A. M., Collins, J. J. (1994). Cefuroxime Axetil in the Treatment of Sinusitis: A Review. Arch Fam Med 3: 165-175 [Abstract]  
  • WORMSER, G. P., KEUSCH, G. T. (1979). Drugs Five Years Later: Trimethoprim-Sulfamethoxazole in the United States. ANN INTERN MED 91: 420-429 [Abstract]